Overview Pharmacokinetic of Tadalafil Co-administered With Tipranavir/Ritonavir to Healthy Male Volunteers Status: Completed Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary Study to assess the effects of single-dose and steady-state tipranavir/ritonavir 500 mg/200 mg on the single-dose pharmacokinetics of tadalafil 10 mg Phase: Phase 1 Details Lead Sponsor: Boehringer IngelheimTreatments: RitonavirTadalafilTipranavir